CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding CollPlant Biotechnologies Ltd changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 17 | 13 | −4 |
| Shares | 1.43M | 1.42M | −14.8K (−1.0%) |
| Value | $9.14M | $7.59M | −$1.55M (−17.0%) |
New holders (1)
Institutions that held CollPlant Biotechnologies Ltd at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 4,780 | $25.6K | 0.00% |
Sold out (5)
Institutions that held CollPlant Biotechnologies Ltd at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Zurcher Kantonalbank (Zurich Cantonalbank) | 23,089 | $147.5K |
| FNY Investment Advisers, LLC | 1,539 | $9.00K |
| GWM Advisors LLC | 500 | $3.19K |
| JPMorgan Chase & Co | 371 | $2.37K |
| Focused Wealth Management, Inc | 242 | $1.55K |